![NFL Biosciences SA](/common/images/company/EU_ALNFL.png)
NFL Biosciences SA (ALNFL)
EU
The current ALNFL market cap is 20.48M. The company's latest EPS is EUR -0.3895 and P/E is -5.47.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 0 | 0 | 0 | 0 | 200k |
Operating Income | -347k | -318k | -902k | -3.08M | -4.23M |
Net Income | -267k | -261k | -978k | -2.44M | -3.75M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 467k | 577k | 3.69M | 2.4M | 3.97M |
Total Liabilities | 56k | 427k | 398k | 1.55M | 3.62M |
Total Equity | 411k | 150k | 3.29M | 844k | 350k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | N/A | N/A | N/A | N/A | N/A |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | N/A | N/A | N/A | N/A | N/A |
Market Cap | 20.48M |
Price to Earnings Ratio | -5.47 |
Price to Sales Ratio | 102.4 |
Price to Cash Ratio | 8.76 |
Price to Book Ratio | 58.51 |
Dividend Yield | - |
Shares Outstanding | 9.61M |
Average Volume (1 week) | 38.77k |
Average Volume (1 Month) | 106.78k |
52 Week Change | -15.81% |
52 Week High | 3.31 |
52 Week Low | 0.94 |
Spread (Intraday) | 0.1 (4.36%) |
Company Name | NFL Biosciences SA |
Address |
199 rue helene boucher castelnau-le-lez 34170 |
Website | https://www.nflbiosciences.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.